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Kinetics of B Cell Responses to Plasmodium falciparum
Erythrocyte Membrane Protein 1 in Ghanaian Women
Naturally Exposed to Malaria Parasites
Paulina Ampomah,* Liz Stevenson,* Michael F. Ofori,† Lea Barfod,* and Lars Hviid*
Naturally acquired protective immunity to Plasmodium falciparum malaria takes years to develop. It relies mainly on Abs,
particularly IgG specific for Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) proteins on the infected eryth-
rocyte surface. It is only partially understood why acquisition of clinical protection takes years to develop, but it probably involves
a range of immune-evasive parasite features, not least of which are PfEMP1 polymorphism and clonal variation. Parasite-induced
subversion of immunological memory and expansion of “atypical” memory B cells may also contribute. In this first, to our
knowledge, longitudinal study of its kind, we measured B cell subset composition, as well as PfEMP1-specific Ab levels and
memory B cell frequencies, in Ghanaian women followed from early pregnancy up to 1 y after delivery. Cell phenotypes and Ag-
specific B cell function were assessed three times during and after pregnancy. Levels of IgG specific for pregnancy-restricted,
VAR2CSA-type PfEMP1 increased markedly during pregnancy and declined after delivery, whereas IgG levels specific for two
PfEMP1 proteins not restricted to pregnancy did not. Changes in VAR2CSA-specific memory B cell frequencies showed typical
primary memory induction among primigravidae and recall expansion among multigravidae, followed by contraction postpartum
in all. No systematic changes in the frequencies of memory B cells specific for the two other PfEMP1 proteins were identified. The
B cell subset analysis confirmed earlier reports of high atypical memory B cell frequencies among residents of P. falciparum–
endemic areas, and indicated an additional effect of pregnancy. Our study provides new knowledge regarding immunity to
P. falciparum malaria and underpins efforts to develop PfEMP1-based vaccines against this disease. The Journal of Immunology,
2014, 192: 000–000.
P
rotective immunity to Plasmodium falciparum malaria ac-
quired after natural exposure is mediated to a large extent
by IgG Abs targeting the asexual blood stages of the par-
asites (1, 2). The P. falciparum erythrocyte membrane protein 1
(PfEMP1) family of high-m.w. proteins mediates adhesion of
erythrocytes by mature P. falciparum parasites to a range of vas-
cular host receptors (3–6). This sequestration of infected erythro-
cytes (IEs) is a major virulence factor (reviewed in Ref. 7), and the
PfEMP1 family therefore constitutes a major target of acquired
protective immunity to P. falciparum malaria (reviewed in ref. 8).
However, the PfEMP1 Ags display an extensive clonal diversity,
which probably goes a long way toward explaining the sluggish
rate at which immunological protection is acquired (reviewed in
Ref. 8). Other immune-evasive mechanisms may also contribute to
delaying acquisition of protection, including parasite interference
with formation and maintenance of immunological memory (re-
viewed in Ref. 9). It has been proposed that parasite-driven ac-
cumulation of atypical memory B cells (phenotypically similar to
the functionally “exhausted” B cells described in HIV-infected indi-
viduals) (10) among residents in P. falciparum–endemic areas may be
one such mechanism (11, 12). Nevertheless, the association between
P. falciparum exposure, atypical memory B cells, and slow acqui-
sition of protective immunity (12–14) remains circumstantial, in
contrast with studies of individuals infected by HIV where dys-
function (“exhaustion”) of pathogen-specific memory B cells has
been demonstrated (10). Furthermore, these previous studies com-
pared P. falciparum–exposed individuals with separate nonexposed
individuals. Their cross-sectional design, and the lack of information
on the Ag specificity of the B cells examined, ignores the contribution
of factors not controlled for (such as coinfections, physiological and
genetic differences, etc.) to the observed phenotypic differences that
were attributed to contrasting P. falciparum exposure alone. Finally,
several recent studies have documented that P. falciparum–specific
B cell memory can be efficiently acquired and maintained for ex-
tended periods in the absence of exposure (15–17), and that “atypical”
P. falciparum–specific memory B cells are not dysfunctional (18).
On this basis, this study was designed to provide further and
more direct evidence regarding the relationship among exposure
to P. falciparum Ags, Ab levels, and immunological memory. We
recruited a longitudinal cohort of pregnant women attending antenatal
clinics in an area of southern Ghana with stable P. falciparum trans-
mission. The participants were followed for up to 1 y postdelivery,
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and peripheral venous blood samples were obtained at recruit-
ment, near delivery, and at the end of individual follow-up. We
used the samples to measure IgG levels and memory B cell fre-
quencies specific for a pregnancy-restricted, VAR2CSA-type
PfEMP1 protein and two other PfEMP1 proteins not restricted to
pregnancy. In addition, we measured the relative frequencies of
phenotypically defined subsets of CD19+ B cells in these samples.
The results were analyzed in terms of time relative to delivery,
parity, and parasitemia. We provide the first direct evidence from
a longitudinal study regarding induction, boosting, and contraction
of B cell memory to the clinically important PfEMP1 Ags during
pregnancy. We also provide evidence that pregnancy has an effect
on the composition of particular B cell subsets. Our findings have
important implications for the understanding of immunity to
P. falciparum malaria and for efforts to develop PfEMP1-based
vaccines against this disease, in particular, vaccines aimed at
protecting against placental malaria, a major cause of maternal suf-
fering and perinatal morbidity and mortality.
Materials and Methods
Study site and study participants
The study was conducted in Assin Foso, a rainforest area ∼80 km North of
Cape Coast, the capital of Central Region, Ghana. Transmission of
P. falciparum parasites remains high in Ghana (19), and historically
our study area is characterized by intense transmission of P. falciparum
parasites with limited seasonal variation (20, 21). Although transmission
appears to have declined in recent years (22), reliable and generally ac-
cessible area-specific information is not available.
We studied 192 adult women (58 primigravidae, 33 secundigravidae, 101
multigravidae) who consented in writing to participate after receiving
explanation of the study design and purpose at their first visit to antenatal
clinics. All the recruited womenwere pregnant (217 to 13 d before delivery),
and were followed for up to14 mo after delivery (see Fig. 1). Apart from
pregnancy and first antenatal visit, no special inclusion or exclusion criteria
were applied. Anamnestic information (age, number of previous pregnancies,
time since last pregnancy, malaria prophylaxis while pregnant, use of
insecticide-impregnated bed nets; Table I) and a venous blood sample
were obtained from all participants at recruitment. From each participant,
a second blood sample was collected near (either before or after) delivery
and a third sample several months after delivery. Three samples were col-
lected from all but 17 women, who were lost to follow-up (only two samples
collected from each; see Fig. 1). The women lost to follow-up did not differ
significantly from the rest for any of the study parameters. Samples from
74 nonpregnant women from the same study area and from 13 nonpregnant
Danish women without exposure to P. falciparum malaria collected as part
of a previous study (23) were included as P. falciparum–exposed and non-
exposed controls for the B cell phenotyping (see later).
The study was approved by the Institutional Review Board of Noguchi
Memorial Institute for Medical Research, University of Ghana (study no.
038/10-11), and by the Regional Research Ethics Committees, Capital
Region of Denmark (protocol H-4-2013-083).
Blood sample collection and preparation
PBMCs and plasma were separated from venous blood samples (8 ml)
collected in heparinized tubes and cryopreserved as described previously (23),
using a controlled temperature gradient device that preserves lymphocyte
function and phenotype (24). P. falciparum asexual blood-stage para-
sitemia at the time of each blood sampling was determined by microscopic
examination of Giemsa-stained blood smears.
Antigens
Recombinant proteins representing the entire ectodomains of three PfEMP1
proteins were produced in Baculovirus-infected insect cells as described
previously (23). These full-length proteins represented the VAR2CSA-type
PfEMP1 protein IT4VAR04 (FV2) and two PfEMP1 proteins involved in
rosetting, HB3VAR06 (FV6) and IT4VAR60 (FV60). Tetanus toxoid (TT)
from Statens Seruminstitut (http://www.ssi.dk) was used as a nonmalaria
control Ag.
Plasma IgG Ab measurements by ELISA
Plasma levels of IgG with specificity for FV2, FV6, and FV60 were
measured by ELISA as described (23). In brief, 96-well, flat-bottom
microtiter plates were coated with Ag, blocked with BSA, and incubated
with prediluted plasma samples for 1 h. Wells were washed and bound Ab
was detected with HRP-conjugated rabbit anti-human IgG and ο-phenylene
diamine. The enzymatic reaction was stopped by addition of H2SO4, optical
densities read at 492 nm, and the specific Ab levels expressed in arbitrary
units: AU = (ODSAMPLE 2 ODBLANK)/(ODPOSCTRL 2 ODBLANK).
Memory B cell frequency determination by ELISPOT
Frequencies of memory B cells with specificity for FV2, FV6, and FV60
were measured by ELISPOT as described previously (23). In brief, cryo-
preserved PMBCs were thawed, washed, adjusted to 2.5 3 106/ml, and
memory B cells were induced to start Ab secretion by stimulating them
with IL-2 and the polyclonal activator R-848 for 72 h. The Ags FV2, FV6,
FV60, and TT were added to separate wells of prewetted ELISPOT plates,
and the plates were incubated overnight (4˚C). After washing and blocking
of the plates, stimulated PBMCs were added (duplicate wells) and the
plates were incubated (37˚C, 5% CO2, 24 h). After washing, evidence of
Ab-secreting cells was detected by HRP-conjugated rabbit anti-human IgG
followed by 3,39,5,59-tetramethylbenzidine. The plates were finally washed
under running tap water and dried in the dark. The number of spots was
determined with an automated ImmunoSpot reader.
B cell phenotyping
Phenotyping of B cell subpopulations was done essentially as described
elsewhere (12). In brief, PBMC aliquots (1 3 106 cells, 100 ml) were
labeled (20 min, room temperature) with saturating amounts of PE.CF594-
CD10 (catalog no. 562292; BD Biosciences, Albertslund, Denmark),
PerCP-CD19 (catalog no. 561295; BD Biosciences), FITC-CD20 (catalog
no. 555742; BD Biosciences), PE-CD21 (catalog no. 555749; BD Bio-
sciences), and PE.Cy5-CD27 (catalog no. 560609; BD Biosciences). After
removal of unbound Ab by washing, forward scatter/side scatter-gated
events were collected on a Beckman Coulter FC500 instrument. List-mode
data files were subsequently analyzed in Kaluza software (Beckman
Coulter, Albertslund, Denmark) to determine the frequencies of B cell
subsets using a predefined gating strategy (see Fig. 4).
Statistical analysis
The impact of time of sampling (recruitment, near-delivery, follow-up) and
parity (primigravid, multigravid) on IgG levels, memory B cell frequencies,
and B cell phenotypes were evaluated by two-way ANOVA. Cohort running
means (and the associated 95% confidence intervals) of Ab levels and
memory B cell frequencies were determined from interpolated values for
individual donors. For this, the Ab level and memory B cell frequency were
assumed to change linearly from the values obtained at the first to the values
obtained at the second, or from the second to the third, time points. Cal-
culated values for individual donors at time points before the first or after the
last were not included, and cohort means were not calculated where ,10
individual estimates were available. One-way ANOVA was used for in-
tergroup comparisons (unexposed control donors versus longitudinal or
cross-sectional cohort donors and cross-sectional cohort donors versus
pregnant or nonpregnant longitudinal cohort donors). Confidence intervals
were calculated as described previously (25).
Results
Plasma levels of PfEMP1-specific IgG reflect recent Ag
exposure
We collected peripheral blood samples from the study participants
at recruitment, near delivery, and several months postpartum (Fig. 1).
A postpartum sample was not collected from a minority of women
(n = 17), who were lost to follow-up. Levels of IgG specific for the
three recombinant PfEMP1 constructs FV2, FV6, and FV60, and for
the control Ag TT were measured in plasma isolated from each
of these samples. Individual responses to the PfEMP1 constructs
varied among donors and over time, but were consistently above
negative cutoff in the large majority of the women at most time
points (Fig. 2A–C). The high variability among donors and over
time is not surprising and is in line with previous data (26). It
almost certainly reflects heterogeneity in age, parity, bed net use,
and so on (Table I), not least because of the highly likely marked
heterogeneity in parasite Ag exposure (whether and when infec-
tion occurred during pregnancy). The variability of TT-specific
responses was much lower, as a sharp increase in TT-specific
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IgG from recruitment to delivery, followed by steady levels post-
partum was seen for most participants (Fig. 2D). Again, these more
uniform responses are not surprising, because TT vaccination of
all pregnant women is a standard part of antenatal care in Ghana.
The pattern we observed is thus evidence of an overall good ad-
herence to this practice, and it is likely that the minority of women
who did not show the typical response were women who did not
receive the scheduled TT vaccination.
To reveal population-level patterns in Ag-specific IgG reactivity,
we plotted the changes in the overall mean IgG level and associated
95% confidence intervals (see Materials and Methods for details
on calculations) over time (Fig. 2E–H). Despite the individual
variability, this revealed clear differences between responses to
the VAR2CSA-type PfEMP1 Ag FV2 (Fig. 2E) and the other two
PfEMP1 constructs (FV6, FV60; Fig. 2F and 2G).
FV2-specific IgG levels increased from the earliest time points
included (∼210 d before delivery, corresponding to about week 10
of gestation) until delivery, followed by a steady decline until
∼250 d postpartum (Fig. 2E). The average FV2-specific IgG re-
sponse was consistently lower among primigravidae than among
multigravidae at all but the earliest time points. Furthermore,
FV2-specific IgG levels started to increase earlier, increased at
a higher rate, and peaked higher among multigravidae than among
primigravidae (Fig. 2E). The rate of postpartum decline, which
was lower than what would be expected from simple catabolic
decay (the overall catabolic half-life of IgG is ∼26 d) was similar
regardless of parity. Average levels of FV2-specific IgG started
increasing again ∼250 d postpartum, possibly reflecting a new
pregnancy, and thereby likely (re)exposure to VAR2CSA-expressing
P. falciparum, in some donors, although this was not assessed at
time of follow-up. The observed pattern was supported by two-
way ANOVA, which revealed highly significant effects on FV2-
specific IgG responses of time of sampling (recruitment, near-
delivery, or follow-up; p = 0.005) and parity (primigravid or
multigravid; p , 0.001).
In marked contrast with the FV2-specific IgG responses, average
levels of FV6- (Fig. 2F) and FV60-specific IgG (Fig. 2G) did not
vary systematically with time (p = 0.78 and p = 0.20 for FV6
and FV60, respectively). As for FV2, levels of FV6- and FV60-
specific IgG depended significantly on parity (p = 0.01 and p =
0.001, respectively); but in contrast with FV2, levels of FV6- and
FV60-specific IgG were higher among primigravidae than among
multigravidae. Finally, a strong effect of time, but not parity, on
TT-specific IgG responses was apparent (Fig. 2H), and this was
confirmed by statistical analysis (p , 0.001 and p = 0.97, re-
spectively). No significant interaction between time and parity was
detected for any of the Ab specificities (p = 0.96, 0.48, 0.41, and
0.26 for FV2, FV6, FV60, and TT, respectively).
These findings confirm and markedly strengthen earlier data
that PfEMP1-specific IgG levels reflect recent natural exposure to
P. falciparum parasites (reviewed in Ref. 27). Second, they show that
pregnancy is associated with a marked IgG response to VAR2CSA-
type PfEMP1 (reviewed in Ref. 28). Third, the levels of these latter
Abs decline fairly rapidly postdelivery, when pregnancy-restricted
P. falciparum Ags are no longer present (23, 29, 30). This contrasts
with the postdelivery levels of TT-specific IgG, which remained
high throughout follow-up as expected.
Frequencies of PfEMP1-specific memory B cells expand and
contract in response to Ag
Much less is known about PfEMP1-specific B cell memory. In
a previous cross-sectional study, we concluded that FV2-specific
B cell memory can be maintained stably for many years after
exposure (23), but the study design did not allow detection and
analysis of transient changes in memory B cell frequencies during
and shortly after pregnancy. This deficiency was therefore
addressed in this study. As was the case for IgG levels, frequencies
of PfEMP1-specific memory B cells varied considerably among
donors and over time (Fig. 3A–C). However, plotting changes in
overall mean memory B cell frequencies (Fig. 3E–G) again revealed
temporal patterns and differences among the Ags that were not
easily appreciated in the plots of individual memory B cell fre-
quency kinetics.
The temporal changes and the parity-dependent differences in
the memory B cell frequencies (Fig. 3) were consistent with the
corresponding IgG responses (Fig. 2). Frequencies of FV2-specific
memory B cells (Fig. 3A) initially increased earlier and faster, and
also peaked earlier and higher, among multigravidae than primi-
gravidae. This was followed by a decline that started near delivery
FIGURE 1. Schematic diagram of timing of sample collection from
longitudinal cohort women. Blood samples were collected at recruitment
(d), near delivery (▴), and 3–14 mo postdelivery (n). Seventeen women
were lost to postdelivery follow-up. Collection times are shown relative to
time of delivery (day 0).
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in the multigravidae and several months later among the primi-
gravidae. As for the FV2-specific IgG responses, a secondary in-
crease in FV2-specific memory B cells was apparent from ∼250 d
postpartum (Fig. 3A). This supports the earlier mentioned hy-
pothesis of re-exposure to parasites expressing VAR2CSA-type
PfEMP1 after becoming pregnant again, indicated by the coinci-
dent increase in FV2-specific IgG levels. Results of the two-way
ANOVA were consistent with the observed pattern. Thus, both
parity and time had an effect on FV2-specific memory B cell
frequencies. However, the levels of significance (p = 0.12 and
0.09, respectively) were considerably lower because of interaction
between time and parity (p = 0.08), reflecting the substantially
slower response kinetics among primigravidae than multigravidae.
Frequencies of FV6- and FV60-specific memory B cells (Fig. 3F
and 3G) were much more stable over time (p = 0.87 and 0.29,
respectively), and with less parity-dependent differences (p = 0.27
and 0.73, respectively). Again, nontrivial interaction between time
and parity was evident for both Ags (p = 0.05 and 0.17, respec-
tively). This appeared mainly because of a modest and transient
postpartum increase in the average FV6- and FV60-specific mem-
ory B cell frequencies among primigravidae (Fig. 3F and 3G).
Frequencies of TT-specific memory B cells (Fig. 3H) depended
strongly on time (p . 0.001) as expected because of the TT
booster vaccination received as part of antenatal care, but they
were not affected by parity (p = 0.97). There was no significant
interaction between the effect of time and parity on frequencies
of TT-specific memory B cells (p = 0.26).
Taken together, these results strongly indicate that memory
B cell response to PfEMP1 follows the general pattern of induction,
expansion, and contraction, and also shows the faster and stronger
response upon recall compared with primary exposure.
B cell subset composition is affected by pregnancy and is
associated with residence in an area of stable P. falciparum
transmission
Several studies have reported that frequencies of atypical B cells
are increased in P. falciparum–exposed individuals, and that this
may be related to an assumed dysfunction in the acquisition of
protective immunity to this infection (reviewed in Ref. 9). To in-
vestigate this in more detail, we determined the relative proportions
of various phenotypically defined CD19+ B cell subsets (Fig. 4) in
all samples where sufficient cells were available (n = 173, n = 180,
and n = 161 at recruitment, near-delivery, and follow-up, respec-
tively), and compared the results with data obtained from a separate
cohort of 74 nonpregnant women living in the same area and 13
nonpregnant Danish women without P. falciparum exposure (Fig. 5).
Table I. Characteristics of study participants
Exposed, Pregnant Exposed, Nonpregnant Nonexposed, Nonpregnant
Donors, n 192 74 13
Median age at enrollment, y (range)a 28 (15–44) 30 (17–54) 37 (23–54)
Mean no. of pregnancies (range)a 2 (0–7) 2 (0–11) 2 (0–4)
Parasitemic at sampling (proportion) 0.4b 0.09 —
Malaria prophylaxis during pregnancya 0.62 — —
ITN usea 0.47 0.61 —
aSelf-reported.
bAt any sampling. The prevalence of parasitemia at recruitment was much higher (0.33) than at the two subsequent samplings (0.07 each).
FIGURE 2. Temporal changes in plasma
IgG levels. Levels of IgG specific for FV2
(A), FV6 (B), FV60 (C), and TT (D) in in-
dividual primigravid (red lines) and multi-
gravid (blue lines) donors at different time
points before and after delivery are shown.
Negative cutoffs (means + 2 SD of levels in
negative control donors) are indicated by
gray shading (A–C). Overall mean levels
(heavy black lines) and 95% confidence
intervals (gray shading) of IgG specific for
FV2 (E), FV6 (F), FV60 (G), and TT (H) at
different time points before and after de-
livery are also shown. Finally, mean levels
among primigravidae only (red lines) or
multigravidae only (blue lines) are shown
(E–H). Only mean levels based on data from
at least 10 individual donors are shown (E–
H). Time of delivery is marked by a vertical
black line in all panels.
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Within the longitudinal cohort, the composition of CD19+ B cell
subsets varied over time, and statistically significant variation was
detectable in several subsets. Thus, the relative frequency of
CD102CD21+CD272 (naive, p = 0.02) cells among all CD19+
B cells (Fig. 5A) increased from recruitment until ∼250 d postpartum,
followed by a decrease. A similar picture was seen for CD102
CDCD21+CD27+ (classical memory, p = 0.01) cells (Fig. 5C),
except that the decrease after 250 d postpartum was not evident. In
contrast, the average relative frequency of triple-negative (CD102
CD212CD272, p , 0.001) atypical memory B cells (Fig. 5B)
decreased initially, followed by an increase toward the end of the
follow-up period. This was also the case (p = 0.04) for CD10+
immature B cells (Fig. 5D) except for the late increase, which was
not discernable in this subset. The CD102CD202CD212CD27+
(plasma cells, p = 0.33) and CD102CD20+CD212CD27+ (acti-
vated B cells) subsets did not vary significantly over time (Fig. 5E
and 5F). Parity did not significantly affect the relative frequency of
any of the subsets (p . 0.36 in each case). Significant interaction
between time and parity was only detected for atypical memory
B cells (p = 0.02; p . 0.23 for all other subsets), where the rate of
the postpartum decline appeared to be higher among primigravidae
than among multigravidae. Subset relative frequencies did not
differ according to whether the donor was parasitemic at the time
of sampling (p . 0.29 for all subsets), whereas the relative fre-
quencies of naive B cells and atypical memory B cells (p = 0.06
and p = 0.004, respectively) in particular, and to a lesser extent
classical memory B cells and immature B cells (both p = 0.10),
depended on pregnancy status.
The B cell subset composition among nonpregnant Danish
control women without malaria exposure (Fig. 5H) was markedly
different from that of P. falciparum–exposed Ghanaian women
(Fig. 5G and 5H). Thus, the relative frequency of naive B cells
was substantially higher among the Danish than among the
Ghanaian women, whether samples from the longitudinal study
(Fig. 5G) or the separate cross-sectional study (Fig. 5H) were used
(p , 0.001 in both cases). In contrast, the relative frequencies of
atypical memory B cells and activated B cells were substantially
FIGURE 3. Temporal changes in memory
B cell frequencies. Frequencies of B cells
secreting IgG specific for FV2 (A), FV6 (B),
FV60 (C), and TT (D) in individual primi-
gravid (red lines) and multigravid (blue
lines) donors at different time points before
and after delivery are shown. Overall mean
levels (heavy black lines) and 95% confi-
dence intervals (gray shading) of B cells
secreting IgG specific for FV2 (E), FV6 (F),
FV60 (G), and TT (H) at different time
points before and after delivery are also
shown. Finally, mean levels among primi-
gravidae only (red lines) or multigravidae
only (blue lines) are shown (E–H). Only
mean levels based on data from at least 10
individual donors are shown (E–H). Time of
delivery is marked by a vertical black line in
all panels.
FIGURE 4. Gating strategy for phenotyping of B cell subsets. B cells
were identified by gating on CD19+ cells. Subsets of CD19+ cells were
subsequently designated as immature B cells (CD10+), naive B cells
(CD102CD21+CD272), classical memory B cells (CD102CD21+CD27+),
atypical memory B cells (CD102CD212CD272), plasma cells (CD102
CD202CD212CD27+), and activated B cells (CD102 CD20+CD212CD27+),
respectively. Plots and percentages shown are representative examples.
Color coding corresponds to that used in Fig. 5G and 5H.
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lower among the Danish than among the Ghanaian women,
whether samples from the longitudinal study or the separate cross-
sectional study were used (p , 0.001 in all cases). The frequen-
cies of classical memory B cells, immature B cells, and plasma
cells among the Danish donors were not significantly different
from the corresponding frequencies among the Ghanaian donors
(p . 0.3 in all cases).
Overall, our B cell phenotype data confirm previous reports that
the relative frequencies of different B cell subsets in individuals
living in areas of stable P. falciparum transmission differ from
those in individuals from nonendemic areas. The cause(s) of this
difference is unclear, however. Although our data clearly suggest
that pregnancy does have an impact on subset composition, pres-
ence or absence of P. falciparum parasites at the time of sampling
appears to be irrelevant. Most importantly, however, our study
does not resolve whether overall B cell phenotypes are affected by
long-term P. falciparum exposure, as suggested by previous in-
direct evidence, or whether other differences between the Gha-
naian and Danish donors (race, living conditions, other infections,
etc.) are equally or more important determinants.
Discussion
Placental malaria is caused by the selective accumulation of
P. falciparum-IEs (reviewed in Ref. 31). The sequestration of IEs
on the maternal side of the placenta is mediated by parasite-
encoded VAR2CSA-type PfEMP1 proteins that are expressed on
the IE surface and have high affinity for low-sulfated chondroitin
sulfates in the intervillous space (32, 33). Placental malaria is
a well-recognized cause of maternal morbidity such as severe
anemia and of substantial perinatal morbidity and mortality (34).
Expression of VAR2CSA-type PfEMP1 proteins appears restricted
to pregnancy, which explains why primigravidae living in areas of
stable transmission of P. falciparum parasites are fully susceptible
to placental malaria despite enjoying substantial protection from
P. falciparum malaria in general, acquired during childhood and
adolescence (reviewed in Refs. 28, 35). In such areas, suscepti-
bility to placental malaria declines in subsequent pregnancies,
reflecting acquisition of specific immunity against the placenta-
sequestering parasites. It is thus well established that levels of
VAR2CSA-type, PfEMP1-specific IgG at the time of delivery de-
pend on parity among women living in areas with stable trans-
mission of P. falciparum parasites, and that these IgG levels are
associated with clinical protection from placental malaria (32).
The causal relation between levels of VAR2CSA-type, PfEMP1-
specific IgG and clinical protection is underpinned by several lines
of investigation, not least is the ability of specific IgG to inhibit
and reverse adhesion of IEs to chondroitin sulfate A (CSA) (32,
36–38). A vaccine to protect pregnant women and their offspring
from placental malaria thus appears feasible and is currently in
development (28). All this notwithstanding, little is known about
the kinetics of VAR2CSA-specific Ab responses during preg-
nancy, and only a single cross-sectional study has reported on their
levels in nonpregnant, P. falciparum–exposed women (23). No
longitudinal studies have compared Ab responses to VAR2CSA-
type PfEMP1 with responses specific for other pregnancy-unrestricted
PfEMP1 Ags in the same donors, let alone compared changes in IgG
levels with the kinetics of the accompanying memory B cell re-
sponse or studied constructs representing the full ectodomains of
these clinically important Ags. This study was designed to over-
come some of these deficiencies.
We found that levels of IgG with specificity for a recombinant
protein (FV2), representing the full ectodomain of the VAR2CSA-
type PfEMP1 IT4VAR04 (39), varied considerably among donors
and over time (Fig. 2A), in good agreement with an earlier similar
study of Abs to the immunodominant DBLεPAM_D5 domain of
VAR2CSA (26). Nevertheless, mean levels of FV2-specific IgG
FIGURE 5. Temporal changes in peri-
pheral blood B cell subsets. Frequen-
cies of phenotypically defined naive
B cells (CD19+CD102CD21+CD272)
(A), atypical memory B cells (CD19+
CD102CD212CD272) (B), classical
memory B cells (CD19+CD102CD21+
CD27+) (C), immature B cells (CD19+
CD10+) (D), plasma cells (CD19+CD102
CD202CD212CD27+) (E), and activated
B cells (CD19+CD102 CD20+CD212
CD27+) (F) at different time points before
and after delivery are shown. Graph
layout and color coding of (A)–(F)
corresponds to that used in Figs. 2
and 4. Relative percentages of circu-
lating CD19+ B cell subsets at different
time points before and after delivery
(G), and in a separate cohort of sym-
patric nonpregnant women (GH) and in
Danish nonpregnant women without
P. falciparum exposure (DK) (H). Color
coding of (G) and (H) correspond to the
little square boxes shown in the upper
right corner of (A)–(F).
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increased over time from ∼150 d before delivery (the earliest time
point with sufficient data available) until delivery (Fig. 2E). The
rate of increase was faster and the peak level higher, among mul-
tigravidae compared with primigravidae (Fig. 2E). After giving
birth, levels started to decrease steadily until ∼250 d postpartum,
where averages started to increase once again. Apart from the very
earliest time points studied, levels of FV2-specific IgG were above
negative cutoff in the large majority of samples at all time points
studied. This data set on the kinetics of IgG responses to
VAR2CSA-type PfEMP1, which is arguably the most compre-
hensive and definitive of its kind so far, is in general in good
agreement with previous reports. Thus, O’Neil-Dunne et al. (40)
showed that CSA adhesion-inhibitory plasma Abs were generally
absent early in pregnancy but increased steadily toward delivery,
and this increase occurred earlier and faster in multigravidae than
in primigravidae. Other studies have yielded similar results (30,
41, 42). However, it should be emphasized that the overall trend
obviously masks transient responses where levels increase, then
decline before delivery in some (mainly multigravid) women (43)
or show more complex dynamics (26). Less data are available
regarding changes in VAR2CSA-Ab levels postpartum. Staalsoe
et al. (30) reported that delivery levels of IgG specific for CSA-
adhering IEs declined substantially over the following 6 mo, in
agreement with our recent report that most previously pregnant
women from an area of stable P. falciparum transmission had little
or no FV2-specific IgG (23). Although other authors reported the
half-life of VAR2CSA-specific IgG to be very long (several to
many decades), their conclusions were based on extrapolations from
measurements in pregnant women only, which probably leads to
gross overestimation (26). Overall, the evidence suggest that
levels of IgG to VAR2CSA-type PfEMP1 are not maintained be-
tween successive pregnancies and start declining as soon as the
parasites expressing this Ag type disappear, that is, at delivery (29,
30). This would be in line with the general consensus that PfEMP1-
specific IgG responses tend to be transient and that levels of these
Abs thus reflect recent exposure (44, 45). With respect to the late
postpartum secondary increase in average FV2-specific IgG lev-
els that we observed (Fig. 2E), it is tempting to speculate that it
indicates secondary pregnancies in some cohort members during
follow-up. Unfortunately, this was not investigated, but the hy-
pothesis is supported by the similar changes in Ab levels over the
course of two pregnancies observed in an earlier study (30) and by
our data on TT-specific IgG (Fig. 2H) and FV2- and TT-specific
memory B cell kinetics (Fig. 3E and 3H).
IgG levels specific for the two other full-length recombinant
PfEMP1 proteins studied, HB3VAR06 (FV6) and IT4VAR60
(FV60), did not vary systematically with time (Fig. 2B, 2C, 2F, and
2G). The FV2-specific response discussed earlier is thus in all
likelihood elicited by exposure to infecting parasites expressing
VAR2CSA-type PfEMP1 rather than a nonspecific or cross-reactive
response to parasites expressing other PfEMP1 types. It has previ-
ously been shown that parasitemia among pregnant women in areas
of stable P. falciparum transmission is dominated by parasites
expressing VAR2CSA-type PfEMP1 proteins indicative of ongoing
placental infection (46, 47). Nevertheless, it appears plausible that
the higher average levels of FV6- and FV60-specific IgG observed
among primigravidae than multigravidae (Fig. 2F and 2G), in
marked contrast with the FV2-specific responses (Fig. 2E), reflect
boosting of pre-existing immunity specific for these Ags caused
by placenta-sequestering parasites (which are more prevalent in
primigravidae) switching to expression of FV6- and FV60-like
PfEMP1 proteins. With the exception of a minority of primi-
gravidae, levels of IgG specific for the unrelated Ag TT increased
sharply from recruitment to delivery in essentially all study
participants and were maintained at high levels throughout the
follow-up period (Fig. 2H). This pattern likely reflects an en-
couragingly high level of adherence to the policy of TT vac-
cination as part of the antenatal care program in Ghana.
The observed transience of the FV2-specific IgG response
(Fig. 2E), in marked contrast with the sustained TT-specific
response (Fig. 2H), might suggest an underlying defect in the
memory B cell response to VAR2CSA-type PfEMP1 proteins, and
by extension to PfEMP1 and other clinically relevant P. falciparum
Ags in general. In fact, this has repeatedly been proposed as an
important underlying cause of the sluggish development of pro-
tective immunity to P. falciparum malaria (reviewed in Ref. 9).
However, we did not find evidence of such a defect in our previous
cross-sectional study on this issue (23), and other reports support
this conclusion (15–17, 48). As in the earlier study (23), we an-
alyzed in this study the frequency of B cells secreting IgG specific
for the study Ags after nonspecific in vitro stimulation, as a mea-
sure of Ag-specific circulating memory B cells (49). The overall
frequency of FV2-specific memory B cells increased from low
levels at the earliest time point studied to a peak 10–15 times
higher near delivery, then declining again (Fig. 3A and 3E). How-
ever, the initial increase happened earlier, was faster, and peaked
earlier among multigravidae compared with primigravidae (Fig. 3E).
This parity-related difference in kinetics strongly implies that vigor-
ous recall responses dominated among the multigravidae, in con-
trast with slower primary FV2-specific immune responses among
the primigravidae. The increase in the frequency of FV2-specific
B cells was followed by a contraction of the B cell response after
disappearance of specific Ags. This would be expected to occur
earlier and often well before delivery (because of the rapid im-
mune response) among multigravidae than among primigravidae,
where parasitemia often persists until delivery (reviewed in Ref.
50). As was the case for the FV2-specific IgG responses, a sec-
ondary increase in the mean frequency of FV2-specific memory
B cells was observed from day 250 onward (Fig. 3E), likely re-
flecting new pregnancies during follow-up as mentioned earlier.
We did not observe convincing systematic temporal changes in
the frequencies of memory B cells specific for the two PfEMP1
proteins not restricted to pregnancy (Fig. 3B, 3C, 3F, and 3G).
However, the minor peaks in both FV6- and FV60-specific memory
B cell frequencies observed among primigravidae shortly after de-
livery might be related to the proposed boosting effect of placenta-
dwelling parasites switching from VAR2CSA-type PfEMP1 to
PfEMP1 proteins resembling FV6 and FV60. Because additional
supportive evidence is lacking, this is presently conjecture. The
kinetics of the memory B cell response to TT (Fig. 3D and 3H)
resembled the FV2-specific response (Fig. 3A and 3E), including
a secondary increase beginning about day 250, which lends further
support to the notion of new pregnancies in some cohort members
during follow-up. The only real difference was that TT-specific
memory B cell kinetics unsurprisingly did not depend on parity
(Fig. 3H).
Could the similar memory B cell responses to these two Ags,
combined with the markedly different (transient versus sustained)
IgG kinetics, indicate the existence of fundamentally different
defensive strategies against different types of infections? In the case
of infections like malaria, “mobilization” (of memory B cells)
might suffice for adequate control, whereas other infections (e.g.,
with toxin-producing bacteria like Clostridium tetani) can only be
successfully controlled if a “standing army” (of Abs) is present at
all times. If so, it might be unjustified to interpret the often low
and transient Ab responses to P. falciparum Ags as evidence of
immune dysfunction. Further studies are clearly required to con-
firm or refute this postulate.
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The hypothesis that parasite-specific immune dysfunction can
explain the slow rate at which protective immunity is acquired has
received new attention following a series of studies reporting in-
creased frequencies of so-called atypical memory B cells among
residents of areas with stable transmission of P. falciparum par-
asites (reviewed in Ref. 9). These cells are phenotypically simi-
lar to the predominantly HIV Ag-specific “exhausted” memory
B cells, which can be found in HIV-infected individuals and are
functionally impaired relative to classical memory B cells (10).
Importantly, however, it is not yet known whether the expanded
atypical memory B cell subset seen in P. falciparum–endemic
areas has a corresponding bias toward P. falciparum Ags. Our
phenotypic B cell data support the earlier reports (11, 12, 14), as
we also found much higher frequencies of atypical (CD102
CD212CD272) memory B cells in our Ghanaian donors com-
pared with Danish control donors without P. falciparum exposure
(Fig. 5G and 5H). In addition, we provide evidence that pregnancy
may also cause a (modest) increase of this subset, and present the
first detailed data on changes in various B cell subsets during and
after pregnancy. As in the earlier studies, we can only speculate on
the Ag specificity of the cells in these subsets. The very similar
B cell phenotype data that we obtained from primigravid and
multigravid donors, respectively, despite major differences in their
functional B cell responses, do not lend further support for
a specific role of P. falciparum in explaining high frequencies of
atypical B cells. However, the available evidence suggests that an
impact on atypical B cell frequencies requires long-term parasite
exposure, whereas current parasitemia is of limited consequence
(12). It is thus possible that bouts of parasitemia during pregnancy
do not result in a B cell phenotypic perturbation detectable by
a study of our size. In any case, the proposed links between
atypical memory B cells and P. falciparum remain largely cir-
cumstantial (see Ref. 51 for an exhaustive review). A resolution of
this conundrum must await studies of P. falciparum Ag-specific
B cells rather than general B cell populations.
In conclusion, to our knowledge, we have reported the first de-
tailed longitudinal study of B cell responses to pregnancy-restricted
and -unrestricted PfEMP1 proteins in a cohort of Ghanaian women
followed from early pregnancy up to about a year postdelivery. We
found no functional or phenotypic evidence of malaria-specific
immune dysfunction. Rather, our data show that exposure to
VAR2CSA-type PfEMP1 during pregnancy results in a textbook-
like primary and secondary immune response in primigravidae and
multigravidae, respectively. Our findings contribute to the basic
understanding of immunity to this important infectious disease, to
the clinically important PfEMP1 Ags, and bode well for current
efforts to develop PfEMP1-based malaria vaccines, in particular,
to control the burden of placental malaria in areas of stable
P. falciparum transmission.
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